Sanara Medtech Inc (SMTI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
31.72 -0.27 (-0.84%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 31.72 unch (unch) 16:01 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,912 | -4,440 | -8,092 | -7,994 | -4,445 |
| Depreciation Amortization | 5,133 | 3,680 | 2,371 | 597 | 291 |
| Income taxes - deferred | N/A | N/A | -5,845 | 0 | N/A |
| Accounts receivable | -4,541 | -1,732 | -2,269 | -775 | -962 |
| Accounts payable and accrued liabilities | -424 | 531 | -302 | 167 | -66 |
| Other Working Capital | -412 | -2,873 | 1,058 | -930 | -860 |
| Other Operating Activity | 10,133 | 1,587 | 7,524 | 4,120 | 2,007 |
| Operating Cash Flow | $-24 | $-3,246 | $-5,555 | $-4,815 | $-4,035 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -206 | -265 | -146 | -172 | -544 |
| Net Acquisitions | N/A | -9,943 | -2,516 | N/A | N/A |
| Purchase Of Investment | -5,303 | N/A | -250 | -4,534 | -1,100 |
| Purchase Sale Intangibles | -24 | N/A | -600 | -579 | -1,100 |
| Other Investing Activity | -1,103 | 0 | -600 | -579 | -1,100 |
| Investing Cash Flow | $-6,612 | $-10,207 | $-3,512 | $-5,285 | $-2,744 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 800 | 0 |
| Debt Issued | 29,339 | 9,688 | N/A | N/A | 583 |
| Common Stock Issued | -75 | 911 | N/A | 28,939 | 39 |
| Other Financing Activity | -11,898 | -959 | -627 | -1,443 | 0 |
| Financing Cash Flow | $17,367 | $9,641 | $-627 | $28,297 | $622 |
| Beginning Cash Position | 5,147 | 8,959 | 18,653 | 455 | 6,612 |
| End Cash Position | 15,878 | 5,147 | 8,959 | 18,653 | 455 |
| Net Cash Flow | $10,731 | $-3,812 | $-9,694 | $18,198 | $-6,157 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24 | -3,246 | -5,555 | -4,815 | -4,035 |
| Capital Expenditure | -206 | -265 | -147 | -172 | -544 |
| Free Cash Flow | -230 | -3,511 | -5,702 | -4,986 | -4,579 |